Why the study?
Does immunosuppressive therapy reduce all-cause death and heart transplantation in patients with inflammatory cardiomyopathy?
Population
316 patients with inflammatory cardiomyopathy (pooled from 5 randomized controlled trials)
Comparison
Immunosuppressive therapy vs Placebo or conventional treatment
Design
Meta-analysis
Authors
Loading...
Immunosuppressive therapy offers no long-term survival benefit in inflammatory cardiomyopathy; reinforces reliance on supportive care and transplantation evaluation.
Does immunosuppressive therapy reduce all-cause death and heart transplantation in patients with inflammatory cardiomyopathy?
Immunosuppressive therapy does not improve long-term survival or reduce the need for heart transplantation in patients with inflammatory cardiomyopathy, supporting the current reliance on supportive measures or transplantation.
Liu et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: